Skip to main content
Risankizumab has early and lasting benefits in Crohn’s disease
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Risankizumab has early and lasting benefits in Crohn’s disease
User login
Username
Password
Reset your password
Concept
Lead
score
Crohn Disease
1
1
Remission
0
0.86
Biologic Therapy
0
0.59
Pain Management
0
0.5
Abdominal Pain
0
0.41
Abdomen
0
0.23
Pain
0
0.23
Psoriasis
0
0.21
Child
0
0.16
Arizona
0
0.08
C-Reactive Protein (CRP)
0
0.08
Cytokines
0
0.08
Food and Drug Administration (FDA)
0
0.08
Health Care Reform
0
0.08
Immunoglobulin A (IgA)
0
0.08
Inflammatory Bowel Disease
0
0.08
Interleukin
0
0.08
Intravenous
0
0.08
Monoclonal Antibody
0
0.08
New York
0
0.08
Outpatient Clinic
0
0.08
Plaque Psoriasis
0
0.08
Specialty
Lead
score
Internal Medicine
1
1
Gastroenterology
0
0.8
Family Medicine/Primary Care
0
0.9